Dr Carl White
Research Fellow
Department of Biochemistry and Pharmacology
29 Scholarly works
1 Projects
HIGHLIGHTS
2025
Research grants (ARC, NHMRC, MRFF)
Chemokines as Novel Nucleic Acid Sensors: A New Function in Innate Immunity
2024
Journal article
ACTION3 Phase 3 Clinical Trial Assessing the Efficacy and Safety of DMX-200 (Repagermanium): Mid-trial Safety Assessment and Pharmacometric Model-Informed Pediatric Dose Selection
DOI: 10.1681/asn.2024qfbcfxw72024
Journal article
CXCL17 induces activation of human mast cells via MRGPRX2
DOI: 10.1111/all.160362024
Journal article
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans
DOI: 10.1126/scisignal.abl37582023
Journal article
NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRET
DOI: 10.1016/j.crmeth.2023.1004222022
Journal article
GPCRs as Therapeutic Targets
DOI: 10.1002/97811195647822021
Journal article
Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2-adrenoceptor in CRISPR/Cas9 genome-edited HEK293T cells at low expression levels
DOI: 10.1002/prp2.779
RECENT SCHOLARLY WORKS
2021
Journal article
Detection of genome-edited and endogenously expressed G protein-coupled receptors
DOI: 10.1111/febs.157292021
Journal article
The use of fluorescence correlation spectroscopy to monitor cell surface β2-adrenoceptors at low expression levels in human embryonic stem cell-derived cardiomyocytes and fibroblasts
DOI: 10.1096/fj.202002268R2021
Journal article
A nanoluciferase biosensor to investigate endogenous chemokine secretion and receptor binding
DOI: 10.1016/j.isci.2020.1020112021
Book Chapter
Bioluminescence Resonance Energy Transfer (BRET) Technologies to Study GPCRs
DOI: 10.1002/9781119564782.ch23